Ticker
BIAFCompany Name
BIOAFFINITY TECHNOLOGIES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -11.58M | -150.71% | $ 7.68M |
3/31/2025 | $ -9.64M | -109.4% | $ 8.81M |
12/31/2024 | $ -8.94M | -95.45% | $ 9.36M |
9/30/2024 | $ -8.34M | -89.02% | $ 9.37M |
6/30/2024 | $ -8.64M | -118.13% | $ 7.32M |
3/31/2024 | $ -8.29M | -167.97% | $ 4.94M |
12/31/2023 | $ -7.88M | -311.11% | $ 2.53M |
9/30/2023 | $ -7.15M | -2223.99% | $ 321.49K |
6/30/2023 | $ -8.9M | -36845.98% | $ 24.16K |
3/31/2023 | $ -6.85M | -119774.73% | $ 5.72K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for BIOAFFINITY TECHNOLOGIES INC is calculated as follows: EBIT [ $ -5.32M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Mar 31, 2023
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |